[go: up one dir, main page]

CN113289057B - Tantalum-coated orthopedic implant material, preparation method thereof and orthopedic implant - Google Patents

Tantalum-coated orthopedic implant material, preparation method thereof and orthopedic implant Download PDF

Info

Publication number
CN113289057B
CN113289057B CN202110548474.XA CN202110548474A CN113289057B CN 113289057 B CN113289057 B CN 113289057B CN 202110548474 A CN202110548474 A CN 202110548474A CN 113289057 B CN113289057 B CN 113289057B
Authority
CN
China
Prior art keywords
tantalum
orthopaedic implant
coating
preparation
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110548474.XA
Other languages
Chinese (zh)
Other versions
CN113289057A (en
Inventor
相冶
魏崇斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing AK Medical Co Ltd
Original Assignee
Beijing AK Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing AK Medical Co Ltd filed Critical Beijing AK Medical Co Ltd
Priority to CN202110548474.XA priority Critical patent/CN113289057B/en
Publication of CN113289057A publication Critical patent/CN113289057A/en
Application granted granted Critical
Publication of CN113289057B publication Critical patent/CN113289057B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/04Metals or alloys
    • A61L27/06Titanium or titanium alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • CCHEMISTRY; METALLURGY
    • C22METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
    • C22CALLOYS
    • C22C14/00Alloys based on titanium
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C24/00Coating starting from inorganic powder
    • C23C24/08Coating starting from inorganic powder by application of heat or pressure and heat
    • C23C24/10Coating starting from inorganic powder by application of heat or pressure and heat with intermediate formation of a liquid phase in the layer
    • C23C24/103Coating with metallic material, i.e. metals or metal alloys, optionally comprising hard particles, e.g. oxides, carbides or nitrides
    • C23C24/106Coating with metal alloys or metal elements only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/08Coatings comprising two or more layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Metallurgy (AREA)
  • Mechanical Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Prostheses (AREA)

Abstract

本发明提供了一种钽涂层骨科植入材料及其制备方法、骨科植入物。该钽涂层骨科植入材料包括依次叠置的基体层、过渡层、钽涂层以及钽表面功能层,基体层为钛或钛合金,过渡层的熔点低于钽的熔点,钽涂层为多孔结构。本申请的钽涂层骨科植入材料一方面提高了钽涂层与过渡层的结合力;另一方面增强了骨长入,从而改善了钽涂层的生物相容性和骨传导性,产生有利于细胞生长的微环境,进而促进骨组织向多孔钽涂层内部生长以形成独特的骨‑植入物界面,显著增强钽涂层骨科植入物在骨组织中的稳定性和功能、加速了骨‑植入物界面的骨整合,此外,本申请的骨科植入物生产成本低、非钽物质的潜在危害性小。

Figure 202110548474

The invention provides a tantalum-coated orthopaedic implant material, a preparation method thereof, and an orthopaedic implant. The tantalum-coated orthopaedic implant material includes a matrix layer, a transition layer, a tantalum coating and a tantalum surface functional layer that are stacked in sequence, the matrix layer is titanium or a titanium alloy, the melting point of the transition layer is lower than that of tantalum, and the tantalum coating is porous structure. On the one hand, the tantalum-coated orthopaedic implant material of the present application improves the bonding force between the tantalum coating and the transition layer; A microenvironment conducive to cell growth, which in turn promotes the growth of bone tissue into the porous tantalum coating to form a unique bone-implant interface, significantly enhancing the stability and function of tantalum-coated orthopedic implants in bone tissue, accelerating The osseointegration of the bone-implant interface is achieved. In addition, the orthopaedic implant of the present application has low production cost and low potential harm of non-tantalum materials.

Figure 202110548474

Description

钽涂层骨科植入材料及其制备方法、骨科植入物Tantalum-coated orthopaedic implant material and preparation method thereof, and orthopaedic implant

技术领域technical field

本发明涉及骨科植入物技术领域,具体而言,涉及一种钽涂层骨科植入材料及其制备方法、骨科植入物。The invention relates to the technical field of orthopedic implants, in particular to a tantalum-coated orthopedic implant material, a preparation method thereof, and an orthopedic implant.

背景技术Background technique

钽具有良好的抗腐蚀性,且在体内环境下钽的离子化程度极低,从而表现出极低的细胞毒性,多孔钽金属髋臼杯等植入产品已经在临床上广泛应用,并取得很好的临床效果。Tantalum has good corrosion resistance, and the degree of ionization of tantalum in the in vivo environment is extremely low, thus showing extremely low cytotoxicity. good clinical effect.

发明专利CN109261958提出了一种表面包覆钽涂层的医用多孔钛或钛合金材料的制备方法,但是该技术包覆在多孔钛合金表面的是一种致密的钽涂层,从而使其植入人体后不存在骨长入的孔隙,进而使得骨组织难以长入到钽涂层中。Invention patent CN109261958 proposes a preparation method of medical porous titanium or titanium alloy material coated with tantalum coating, but the technology is coated with a dense tantalum coating on the surface of porous titanium alloy, so that it can be implanted There are no pores for bone ingrowth in the back of the human body, which makes it difficult for bone tissue to grow into the tantalum coating.

此外,捷迈的钽骨小梁骨植入物是采用化学气相沉积技术加工的,该技术工艺步骤多、技术难度高;另外,由于钽的熔点高,采用传统的粉末冶金方法难以加工;3D打印金属钽,其原料与加工成本高,尤其是钽的比重高造成相同规格的植入物的重量高,植入后易发生沉陷等问题。In addition, Zimmer’s tantalum trabecular bone implants are processed by chemical vapor deposition technology, which has many process steps and high technical difficulties; in addition, due to the high melting point of tantalum, it is difficult to process by traditional powder metallurgy methods; 3D Printing metal tantalum has high raw material and processing costs, especially the high specific gravity of tantalum causes the high weight of the implant of the same specification, and is prone to problems such as subsidence after implantation.

发明内容SUMMARY OF THE INVENTION

本发明的主要目的在于提供一种钽涂层骨科植入材料及其制备方法、骨科植入物,以解决现有技术中骨组织难以长入到钽涂层骨科植入物的问题。The main purpose of the present invention is to provide a tantalum-coated orthopaedic implant material, a preparation method thereof, and an orthopaedic implant, so as to solve the problem that bone tissue is difficult to grow into the tantalum-coated orthopaedic implant in the prior art.

为了实现上述目的,根据本发明的一个方面,提供了一种钽涂层骨科植入材料,包括依次叠置的基体层、过渡层、钽涂层以及钽表面功能层,该基体层为钛或钛合金,过渡层的熔点低于钽的熔点,钽涂层为多孔结构。In order to achieve the above object, according to one aspect of the present invention, there is provided a tantalum-coated orthopaedic implant material, comprising a matrix layer, a transition layer, a tantalum coating and a tantalum surface functional layer stacked in sequence, and the matrix layer is titanium or For titanium alloys, the melting point of the transition layer is lower than that of tantalum, and the tantalum coating has a porous structure.

进一步地,上述钽涂层的孔径大小为10~30μm,优选钽涂层的涂层孔隙率为30~80%,优选钽涂层的厚度为30~60μm。Further, the pore size of the tantalum coating is 10-30 μm, preferably the porosity of the tantalum coating is 30-80%, and the thickness of the tantalum coating is preferably 30-60 μm.

进一步地,上述过渡层的厚度为90~180μm。Further, the thickness of the transition layer is 90-180 μm.

进一步地,上述钽表面功能层为纳米丝状钽酸钙,优选纳米丝状钽酸钙的直径为20~35nm,优选纳米丝状钽酸钙的长度≤500nm。Further, the above-mentioned tantalum surface functional layer is nano-filament calcium tantalate, preferably the diameter of the nano-filament calcium tantalate is 20-35 nm, and preferably the length of the nano-filament calcium tantalate is less than or equal to 500 nm.

进一步地,上述钛合金选自Ti-6Al-4V、Ti-6Al-17Nb、Ti-13Nb-13Zr、Ti-5Zr-3Mo-15Nb中的任意一种。Further, the above-mentioned titanium alloy is selected from any one of Ti-6Al-4V, Ti-6Al-17Nb, Ti-13Nb-13Zr, and Ti-5Zr-3Mo-15Nb.

进一步地,上述过渡层为纯钛或Ti-6Al-4V。Further, the above transition layer is pure titanium or Ti-6Al-4V.

根据本发明的另一方面,提供了一种包括上述钽涂层骨科植入材料的钽涂层骨科植入物,该钽涂层骨科植入物为髋臼杯、髋臼补块、股骨柄中的任意一种。According to another aspect of the present invention, there is provided a tantalum-coated orthopaedic implant comprising the above-mentioned tantalum-coated orthopaedic implant material, and the tantalum-coated orthopaedic implant is an acetabular cup, an acetabular patch, and a femoral stem. any of the .

根据本发明的又一方面,提供了一种上述钽涂层骨科植入材料的制备方法,该制备方法包括依次在基体层上形成过渡层、钽涂层以及钽表面功能层,钽涂层的形成过程包括采用激光熔覆的方法将钽颗粒喷涂在过渡层上,形成钽涂层,其中,激光熔覆的功率小于或等于8.0KW。According to another aspect of the present invention, a preparation method of the above-mentioned tantalum-coated orthopaedic implant material is provided, the preparation method comprising sequentially forming a transition layer, a tantalum coating and a tantalum surface functional layer on the base layer, and the tantalum coating is The forming process includes spraying tantalum particles on the transition layer by means of laser cladding to form a tantalum coating, wherein the power of the laser cladding is less than or equal to 8.0KW.

进一步地,上述制备方法包括:步骤S1,在基体层上喷涂钛粉末或钛合金颗粒,形成过渡层;步骤S2,采用激光熔覆的方法将钽颗粒喷涂在过渡层上,形成钽涂层;步骤S3,将钽涂层与钙盐和强碱溶液进行水热反应,得到钽涂层骨科植入材料。Further, the above preparation method includes: step S1, spraying titanium powder or titanium alloy particles on the base layer to form a transition layer; step S2, using a laser cladding method to spray tantalum particles on the transition layer to form a tantalum coating; Step S3, hydrothermally reacting the tantalum coating with a calcium salt and a strong alkali solution to obtain a tantalum-coated orthopaedic implant material.

进一步地,上述钽颗粒的球形度为0.6~1,优选钽颗粒的平均粒径为5~40μm,和/或钽颗粒的D50为20~30μm。Further, the sphericity of the tantalum particles is 0.6-1, preferably the average particle size of the tantalum particles is 5-40 μm, and/or the D50 of the tantalum particles is 20-30 μm.

进一步地,上述激光熔覆的功率为4.0~8.0KW,优选激光熔覆的光斑直径为20~25mm,优选激光熔覆的光束扫描速度为100~180mm/min,优选采用流量为8~12L/min的惰性气体或氮气对激光熔覆的过程进行保护。Further, the power of the above-mentioned laser cladding is 4.0-8.0KW, the diameter of the spot of the laser cladding is preferably 20-25mm, the beam scanning speed of the laser cladding is preferably 100-180mm/min, and the flow rate is preferably 8-12L/min. min inert gas or nitrogen to protect the laser cladding process.

进一步地,在上述步骤S1中,优选钛粉末或钛合金颗粒的平均粒径各自独立地为70~100μm。Further, in the above step S1, it is preferable that the average particle diameter of the titanium powder or the titanium alloy particle is independently 70 to 100 μm.

进一步地,上述制备方法还包括:对基体层进行表面预处理,优选表面预处理的过程包括:对基体层依次进行打磨处理,得到打磨后基体层;采用氧化铝颗粒在打磨后基体层上进行喷砂处理,得到喷砂后基体层;对喷砂后基体层进行酸蚀处理,优选氧化铝颗粒的平均粒径为350~500μm,优选喷砂处理的压强为0.8~1.2MPa,优选喷砂处理的时间为45~90s;优选采用V(H2O):V(硫酸):V(盐酸)=20:8:4的混合酸进行酸蚀处理,硫酸中H2SO4的质量浓度为40~50%,盐酸中HCl的质量浓度为30~40%,优选酸蚀处理的时间为90~120s。Further, the above-mentioned preparation method further includes: performing surface pretreatment on the base layer, preferably the process of surface pretreatment includes: performing grinding treatment on the base layer in turn to obtain a ground base layer; Sandblasting to obtain a matrix layer after sandblasting; acid etching the matrix layer after sandblasting, preferably the average particle size of the alumina particles is 350-500 μm, and the pressure of the sandblasting treatment is preferably 0.8-1.2MPa, preferably sandblasting The treatment time is 45 to 90s; preferably, the mixed acid of V(H 2 O): V (sulfuric acid): V (hydrochloric acid)=20:8:4 is used for acid etching treatment, and the mass concentration of H 2 SO 4 in the sulfuric acid is 40-50%, the mass concentration of HCl in the hydrochloric acid is 30-40%, and the time of the acid etching treatment is preferably 90-120s.

应用本发明的技术方案,本申请的钽涂层骨科植入材料一方面通过在基体层与钽涂层之间形成一种过渡层,从而减少了钽涂层与基体层之间的热应力,提高了钽涂层与过渡层的结合力;另一方面由于钽涂层的多孔结构为骨组织的长入提供了空间,增强了骨长入,从而改善了钽涂层的生物相容性和骨传导性,产生有利于细胞生长的微环境,进而促进骨组织向多孔钽涂层内部生长以形成独特的骨-植入物界面,显著增强钽涂层骨科植入物在骨组织中的稳定性和功能、加速了骨-植入物界面的骨整合,此外,本申请的钽涂层仅通过钽涂层结构的改进就提高了其骨-植入物界面的骨整合性,与通过引入非钽物质对钽涂层进行预处理的方法相比,本申请的骨科植入物生产成本低、非钽物质的潜在危害性小,具有更好的应用前景。By applying the technical solution of the present invention, the tantalum-coated orthopaedic implant material of the present application forms a transition layer between the base layer and the tantalum coating, thereby reducing the thermal stress between the tantalum coating and the base layer, The bonding force between the tantalum coating and the transition layer is improved; on the other hand, the porous structure of the tantalum coating provides space for the ingrowth of the bone tissue, which enhances the ingrowth of the bone, thereby improving the biocompatibility and the biocompatibility of the tantalum coating. Osteoconductivity, creating a microenvironment conducive to cell growth, which in turn promotes the growth of bone tissue into the porous tantalum coating to form a unique bone-implant interface, significantly enhancing the stability of tantalum-coated orthopedic implants in bone tissue performance and function, accelerated the osseointegration of the bone-implant interface, and in addition, the tantalum coating of the present application improved the osseointegration of its bone-implant interface only through the improvement of the tantalum coating structure, and by introducing Compared with the method for pretreating the tantalum coating by the non-tantalum material, the orthopaedic implant of the present application has lower production cost, less potential harm of the non-tantalum material, and has a better application prospect.

附图说明Description of drawings

构成本申请的一部分的说明书附图用来提供对本发明的进一步理解,本发明的示意性实施例及其说明用于解释本发明,并不构成对本发明的不当限定。在附图中:The accompanying drawings forming a part of the present application are used to provide further understanding of the present invention, and the exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the attached image:

图1示出了实施例1提供的钽涂层髋臼杯的扫描电镜照片;Fig. 1 shows the scanning electron microscope photograph of the tantalum-coated acetabular cup provided in Example 1;

图2示出了实施例1提供的钽涂层髋臼杯的表面功能层的微纳结构图;Fig. 2 shows the micro-nano structure diagram of the surface functional layer of the tantalum-coated acetabular cup provided in Example 1;

图3示出了实施例1提供的髋臼杯骨科植入物的剖视图;以及Figure 3 shows a cross-sectional view of the acetabular cup orthopaedic implant provided in Example 1; and

图4示出了图3的剖视图的A处的局部放大图。FIG. 4 shows a partial enlarged view at A of the cross-sectional view of FIG. 3 .

其中,上述附图包括以下附图标记:Wherein, the above-mentioned drawings include the following reference signs:

1、基体层;2、酸蚀层;3、过渡层;4、钽涂层。1. Base layer; 2. Acid etching layer; 3. Transition layer; 4. Tantalum coating.

具体实施方式Detailed ways

需要说明的是,在不冲突的情况下,本申请中的实施例及实施例中的特征可以相互组合。下面将参考附图并结合实施例来详细说明本发明。It should be noted that the embodiments in the present application and the features of the embodiments may be combined with each other in the case of no conflict. The present invention will be described in detail below with reference to the accompanying drawings and in conjunction with the embodiments.

如背景技术所分析的,现有技术中存在钽涂层骨科植入物制造难度大、钽骨科植入物制造成本高、尤其是骨组织难以长入到钽涂层骨科植入物的问题,为解决骨组织难以长入到钽涂层骨科植入物的问题,本发明提供了一种钽涂层骨科植入材料及其制备方法、骨科植入物。As analyzed in the background art, there are problems in the prior art that the tantalum-coated orthopaedic implant is difficult to manufacture, the manufacturing cost of the tantalum-coated orthopaedic implant is high, and in particular, it is difficult for bone tissue to grow into the tantalum-coated orthopaedic implant. In order to solve the problem that the bone tissue is difficult to grow into the tantalum-coated orthopaedic implant, the present invention provides a tantalum-coated orthopaedic implant material, a preparation method thereof, and an orthopaedic implant.

在本申请的一种典型的实施方式中,提供了一种钽涂层骨科植入材料,包括依次叠置的基体层、过渡层、钽涂层以及钽表面功能层,该基体层为钛或钛合金,过渡层的熔点低于钽的熔点,钽涂层为多孔结构。In a typical embodiment of the present application, a tantalum-coated orthopaedic implant material is provided, comprising a matrix layer, a transition layer, a tantalum coating and a tantalum surface functional layer stacked in sequence, and the matrix layer is titanium or For titanium alloys, the melting point of the transition layer is lower than that of tantalum, and the tantalum coating has a porous structure.

本申请的钽涂层骨科植入材料一方面通过在基体层与钽涂层之间形成一种过渡层,从而减少了钽涂层与基体层之间的热应力,提高了钽涂层与过渡层的结合力;另一方面由于钽涂层的多孔结构为骨组织的长入提供了空间,增强了骨长入,从而改善了钽涂层的生物相容性和骨传导性,产生有利于细胞生长的微环境,进而促进骨组织向多孔钽涂层内部生长以形成独特的骨-植入物界面,显著增强钽涂层骨科植入物在骨组织中的稳定性和功能、加速了骨-植入物界面的骨整合,此外,本申请的钽涂层仅通过钽涂层结构的改进就提高了其骨-植入物界面的骨整合性,与通过引入非钽物质对钽涂层进行预处理的方法相比,本申请的骨科植入物生产成本低、非钽物质的潜在危害性小,具有更好的应用前景。On the one hand, the tantalum-coated orthopaedic implant material of the present application forms a transition layer between the base layer and the tantalum coating, thereby reducing the thermal stress between the tantalum coating and the base layer, and improving the relationship between the tantalum coating and the transition layer. On the other hand, the porous structure of the tantalum coating provides space for the ingrowth of bone tissue, which enhances the ingrowth of the bone, thereby improving the biocompatibility and osteoconductivity of the tantalum coating. The microenvironment for cell growth, which in turn promotes the growth of bone tissue into the porous tantalum coating to form a unique bone-implant interface, which significantly enhances the stability and function of tantalum-coated orthopedic implants in bone tissue, and accelerates bone growth. - Osseointegration of the implant interface, in addition, the tantalum coating of the present application improves the osseointegration of its bone-implant interface only through the improvement of the tantalum coating structure, which is in contrast to the tantalum coating by introducing non-tantalum substances Compared with the method of pretreatment, the orthopaedic implant of the present application has low production cost, less potential harm of non-tantalum substances, and has better application prospects.

在本申请的一种实施例中,上述钽涂层的孔径大小为10~30μm,优选钽涂层的涂层孔隙率为30~80%,优选上述钽涂层的厚度为30~60μm。In an embodiment of the present application, the pore size of the tantalum coating is 10-30 μm, preferably the coating porosity of the tantalum coating is 30-80%, and the thickness of the tantalum coating is preferably 30-60 μm.

上述孔径和孔隙率的钽涂层具有更多的孔隙和更大的比表面积,从而更有利于骨组织的长入,优选的钽涂层厚度有助于尽可能地提供钽涂层骨科植入物容纳骨组织的空间,进而提高了钽涂层骨科植入物在生物体内的稳定性与生物相容性。The tantalum coating with the above-mentioned pore size and porosity has more pores and larger specific surface area, which is more conducive to the ingrowth of bone tissue, and the preferred thickness of the tantalum coating helps to provide tantalum-coated orthopedic implants as much as possible The space for the tantalum-coated orthopedic implant to accommodate bone tissue is improved, and the stability and biocompatibility of the tantalum-coated orthopaedic implant in vivo are improved.

在本申请的一种实施例中,上述过渡层的厚度为90~180μm。In an embodiment of the present application, the thickness of the transition layer is 90-180 μm.

上述厚度的过渡层一方面有助于尽可能地粘结较多的钽颗粒,另一方面又不易于从基体层上脱落。On the one hand, the transition layer of the above thickness helps to bond as many tantalum particles as possible, and on the other hand, it is not easy to fall off from the base layer.

为进一步地提高钽涂层骨科植入材料的生物相容性,优选上述钽表面功能层为纳米丝状钽酸钙,优选纳米丝状钽酸钙的直径为20~35nm,优选纳米丝状钽酸钙的长度≤500nm。In order to further improve the biocompatibility of tantalum-coated orthopaedic implant materials, preferably the above-mentioned tantalum surface functional layer is nano-filament calcium tantalate, preferably the diameter of nano-filament calcium tantalate is 20-35nm, preferably nano-filament tantalum The length of calcium acid is ≤500nm.

为进一步地提高钽涂层骨科植入材料的结合强度,优选上述钛合金选自Ti-6Al-4V、Ti-6Al-17Nb、Ti-13Nb-13Zr、Ti-5Zr-3Mo-15Nb中的任意一种。In order to further improve the bonding strength of the tantalum-coated orthopaedic implant material, preferably the above-mentioned titanium alloy is selected from any one of Ti-6Al-4V, Ti-6Al-17Nb, Ti-13Nb-13Zr, Ti-5Zr-3Mo-15Nb. kind.

为更好地降低钽涂层与基体层之间的热应力,优选上述过渡层为纯钛或Ti-6Al-4V。In order to better reduce the thermal stress between the tantalum coating and the base layer, the transition layer is preferably pure titanium or Ti-6Al-4V.

在本申请的一种典型的实施方式中,提供了一种包括前述钽涂层骨科植入材料的钽涂层骨科植入物,该钽涂层骨科植入物为髋臼杯、髋臼补块、股骨柄中的任意一种。In a typical embodiment of the present application, there is provided a tantalum-coated orthopaedic implant comprising the aforementioned tantalum-coated orthopaedic implant material, and the tantalum-coated orthopaedic implant is an acetabular cup, an acetabular Either block or femoral stem.

本申请的钽涂层骨科植入材料有利于促进骨组织向多孔钽涂层内部生长以形成独特的骨-植入物界面,显著增强钽涂层骨科植入物在骨组织中的稳定性和功能、加速了骨-植入物界面的骨整合具有高耐腐性,采用该钽涂层骨科植入材料制备得到具有一定结构的钽涂层骨科植入物,如髋臼杯、髋臼补块或股骨柄等,可以极大地改善骨科植入物在生物体内的安全性和有效性,提高其使用寿命。The tantalum-coated orthopaedic implant material of the present application is beneficial to promote the growth of bone tissue into the porous tantalum coating to form a unique bone-implant interface, significantly enhancing the stability of the tantalum-coated orthopaedic implant in the bone tissue and Function, accelerates the osseointegration of the bone-implant interface, and has high corrosion resistance. The tantalum-coated orthopaedic implant material is used to prepare tantalum-coated orthopaedic implants with a certain structure, such as acetabular cups, acetabular replacement parts. Blocks or femoral stems, etc., can greatly improve the safety and effectiveness of orthopaedic implants in vivo and increase their service life.

当骨科植入物为髋臼杯时,优选该髋臼杯的有效球形外径为36~72mm,优选该髋臼杯的髋臼高度为22~50mm,优选钽涂层的孔隙率为30~80%。When the orthopaedic implant is an acetabular cup, preferably the effective spherical outer diameter of the acetabular cup is 36-72 mm, preferably the acetabular height of the acetabular cup is 22-50 mm, and preferably the porosity of the tantalum coating is 30-30 mm 80%.

当骨科植入物为股骨柄时,优选该股骨柄的柄体直径为

Figure BDA0003074411460000041
优选股骨柄的CT值为100~280mm,优选钽涂层的孔隙率为30~80%。When the orthopaedic implant is a femoral stem, the diameter of the stem body of the femoral stem is preferably
Figure BDA0003074411460000041
Preferably, the CT value of the femoral stem is 100-280 mm, and the porosity of the tantalum coating is preferably 30-80%.

在本申请的另一种典型的实施方式中,提供了一种钽涂层骨科植入材料的制备方法,该制备方法包括依次在基体层上形成过渡层、钽涂层以及钽表面功能层,钽涂层的形成过程包括采用激光熔覆的方法将钽颗粒喷涂在过渡层上,形成钽涂层,其中,激光熔覆的功率小于或等于8.0KW。In another typical embodiment of the present application, a preparation method of a tantalum-coated orthopaedic implant material is provided, the preparation method comprising sequentially forming a transition layer, a tantalum coating and a tantalum surface functional layer on a base layer, The formation process of the tantalum coating includes spraying the tantalum particles on the transition layer by means of laser cladding to form the tantalum coating, wherein the power of the laser cladding is less than or equal to 8.0KW.

上述技术结合了传统的喷涂技术与激光熔覆技术,创造性的将激光熔覆用于熔化过渡层,并通过激光熔覆功率的控制,使得过渡层熔化,而钽颗粒不熔化或少部分熔化,从而将钽颗粒粘结在熔化态的钛过渡层上,一方面避免了在钽与钛之间的间隙相的形成,并解决了钽金属熔点高、难以融化喷涂的问题。另一方面形成的钽涂层为多孔结构,从而为骨组织的长入提供了空间,增强了骨长入,从而改善了钽涂层的生物相容性和骨传导性,产生有利于细胞生长的微环境,进而促进骨组织向多孔钽涂层内部生长以形成独特的骨-植入物界面,显著增强骨科植入物在骨组织中的稳定性和功能、加速了骨-植入物界面的骨整合,同时,通过钽涂层与钙盐和强碱溶液进行水热反应,得到了具有钽表面功能层的钽涂层骨科植入材料,从而进一步地提高了钽涂层骨科植入材料的综合性能。此外,上述制备工艺简单,成本较低。The above technology combines traditional spraying technology and laser cladding technology, creatively uses laser cladding to melt the transition layer, and controls the laser cladding power to melt the transition layer, while the tantalum particles do not melt or partially melt, Thus, the tantalum particles are bonded on the molten titanium transition layer, on the one hand, the formation of the interstitial phase between tantalum and titanium is avoided, and the problem of high melting point of tantalum metal and difficulty in melting and spraying is solved. On the other hand, the formed tantalum coating has a porous structure, thereby providing space for the ingrowth of bone tissue, enhancing bone ingrowth, thereby improving the biocompatibility and osteoconductivity of the tantalum coating, resulting in favorable cell growth. It promotes the growth of bone tissue into the porous tantalum coating to form a unique bone-implant interface, significantly enhances the stability and function of orthopaedic implants in bone tissue, and accelerates the bone-implant interface. At the same time, through the hydrothermal reaction of tantalum coating with calcium salt and strong alkali solution, a tantalum-coated orthopaedic implant material with a tantalum surface functional layer is obtained, thereby further improving the tantalum-coated orthopaedic implant material. comprehensive performance. In addition, the above-mentioned preparation process is simple and the cost is low.

为进一步地提高上述过渡层、钽涂层以及钽表面功能层的制备效率,优选上述制备方法包括:步骤S1,在基体层上喷涂钛粉末或钛合金颗粒,形成过渡层;步骤S2,采用激光熔覆的方法将钽颗粒喷涂在过渡层上,形成钽涂层;步骤S3,将钽涂层与钙盐和强碱溶液进行水热反应,得到钽涂层骨科植入材料。In order to further improve the preparation efficiency of the above transition layer, tantalum coating and tantalum surface functional layer, preferably the above preparation method includes: step S1, spraying titanium powder or titanium alloy particles on the base layer to form a transition layer; step S2, using a laser The cladding method sprays tantalum particles on the transition layer to form a tantalum coating; in step S3, hydrothermally reacts the tantalum coating with a calcium salt and a strong alkali solution to obtain a tantalum-coated orthopaedic implant material.

为提高本申请的上述步骤S3的水热反应的效率,优选上述水热反应的过程包括:将步骤S2得到的材料浸没在0.2mol/L的磷酸二氢钙和5mol/L的氢氧化钠溶液中,并在80℃的温度条件下持续进行24小时的水热反应,最后去离子水超声清洗,得到成分为纳米丝状碳酸钙的钽表面功能层。当然本领域技术人员也可以参照现有技术进行上述的水热反应,在此不再赘述。In order to improve the efficiency of the hydrothermal reaction of the above-mentioned step S3 of the present application, preferably the process of the above-mentioned hydrothermal reaction includes: immersing the material obtained in the step S2 in 0.2 mol/L calcium dihydrogen phosphate and 5 mol/L sodium hydroxide solution The hydrothermal reaction was continued for 24 hours at a temperature of 80 °C, and finally deionized water was ultrasonically cleaned to obtain a tantalum surface functional layer composed of nano-filament calcium carbonate. Of course, those skilled in the art can also perform the above-mentioned hydrothermal reaction with reference to the prior art, which is not repeated here.

为尽可能地提高钽涂层的孔隙率,优选上述钽颗粒的球形度为0.6~1,优选上述钽颗粒的平均粒径为5~40μm,和/或钽颗粒的D50为20~30μm。其中,上述粒径的钽颗粒可以通过筛分得到。In order to increase the porosity of the tantalum coating as much as possible, the sphericity of the tantalum particles is preferably 0.6-1, the average particle size of the tantalum particles is preferably 5-40 μm, and/or the D50 of the tantalum particles is 20-30 μm. Wherein, the tantalum particles with the above particle size can be obtained by sieving.

在本申请的一种实施例中,上述激光熔覆的功率为4.0~8.0KW,优选激光熔覆的光斑直径为20~25mm,优选激光熔覆的光束扫描速度为100~180mm/min,优选采用流量为8~12L/min的惰性气体对激光熔覆的过程进行保护,优选惰性气体为氮气或氩气,考虑到成本,进一步地选择氮气。In an embodiment of the present application, the power of the above-mentioned laser cladding is 4.0-8.0KW, preferably the spot diameter of the laser cladding is 20-25mm, and the beam scanning speed of the laser cladding is preferably 100-180mm/min, preferably The laser cladding process is protected by an inert gas with a flow rate of 8-12 L/min. Preferably, the inert gas is nitrogen or argon. Considering the cost, nitrogen is further selected.

上述的激光熔覆条件可以尽可能地控制过渡层形成熔融态,而钽颗粒不熔化或少部分熔化,从而尽可能地提高形成多孔隙的钽涂层的附着稳定性,并使得钽颗粒尽可能低均匀粘结于熔化态的过渡层上,从而尽可能地丰富钽涂层的孔隙。The above laser cladding conditions can control the transition layer to form a molten state as much as possible, while the tantalum particles are not melted or partially melted, so as to improve the adhesion stability of the porous tantalum coating as much as possible, and make the tantalum particles as much as possible. Low homogeneous adhesion to the molten transition layer, thereby enriching the porosity of the tantalum coating as much as possible.

为使得到的过渡层能够尽可能地缓减基体层与钽涂层之间的热应力,优选在步骤S1中,钛粉末或钛合金颗粒的平均粒径各自独立地为70~100μm。In order that the obtained transition layer can reduce the thermal stress between the base layer and the tantalum coating layer as much as possible, preferably in step S1, the average particle size of the titanium powder or titanium alloy particles is independently 70-100 μm.

在本申请的一种实施例中,上述制备方法还包括:对基体层进行表面预处理,优选表面预处理的过程包括:对基体层依次进行打磨处理,得到打磨后基体层;采用氧化铝颗粒在打磨后基体层上进行喷砂处理,得到喷砂后基体层;对喷砂后基体层进行酸蚀处理,优选氧化铝颗粒的平均粒径为350~500μm,优选喷砂处理的压强为0.8~1.2MPa,优选喷砂处理的时间为45~90s;优选采用V(H2O):V(硫酸):V(盐酸)=20:8:4的混合酸进行酸蚀处理,硫酸中H2SO4的质量浓度为40~50%,盐酸中HCl的质量浓度为30~40%,优选酸蚀处理的时间为90~120s。In an embodiment of the present application, the above preparation method further includes: performing surface pretreatment on the base layer, preferably, the process of surface pretreatment includes: sequentially grinding the base layer to obtain a ground base layer; using alumina particles Carry out sandblasting treatment on the base layer after grinding to obtain the base layer after sandblasting; carry out acid etching treatment on the base layer after sandblasting, preferably the average particle size of the alumina particles is 350-500 μm, and the pressure of the sandblasting treatment is preferably 0.8 ~1.2MPa, preferably the sandblasting time is 45~90s; it is preferable to use the mixed acid of V(H 2 O): V (sulfuric acid): V (hydrochloric acid)=20:8:4 for acid etching treatment, H in the sulfuric acid The mass concentration of 2 SO 4 is 40-50%, the mass concentration of HCl in the hydrochloric acid is 30-40%, and the time of the acid etching treatment is preferably 90-120 s.

上述的预处理有利于提高本申请的基体层的表面粗糙度,从而有利于喷砂处理的进行,为进一步地提高酸蚀处理的效率。优选对钛合金基体先后经过200目、800目砂纸打磨3min,随后用1200目砂纸打磨5min;并在丙酮溶液中超声清洗5~8min;随后用纯化水超声清洗5min,然后吹干备用。当然本领域技术人员也可以根据需要调整打磨处理的具体条件,在此不再赘述。其中的混合酸组成及酸蚀处理的时间有利于控制酸蚀处理的程度,从而保证基体层的粗糙度,进而提高基体层与过渡层的结合强度。The above-mentioned pretreatment is beneficial to improve the surface roughness of the base layer of the present application, thereby facilitating the sandblasting treatment, in order to further improve the efficiency of the acid etching treatment. Preferably, the titanium alloy substrate is sanded with 200-mesh and 800-mesh sandpaper for 3 minutes, and then sanded with 1200-mesh sandpaper for 5 minutes; ultrasonically cleaned in acetone solution for 5-8 minutes; then ultrasonically cleaned with purified water for 5 minutes, and then dried for use. Of course, those skilled in the art can also adjust the specific conditions of the grinding process as needed, which will not be repeated here. The composition of the mixed acid and the time of the acid etching treatment are beneficial to control the degree of the acid etching treatment, thereby ensuring the roughness of the base layer and improving the bonding strength between the base layer and the transition layer.

以下将结合具体实施例和对比例,对本申请的有益效果进行说明。The beneficial effects of the present application will be described below with reference to specific embodiments and comparative examples.

实施例1Example 1

对Ti-6Al-4V的髋臼杯进行钽涂层处理,该髋臼杯的有效球形外径为52mm,髋臼的高度为44mm。The acetabular cup of Ti-6Al-4V was treated with tantalum coating, the effective spherical outer diameter of the acetabular cup was 52 mm, and the height of the acetabulum was 44 mm.

对髋臼杯的外表面进行表面预处理:对髋臼杯的外表面先后经过200目、800目砂纸打磨3min,随后用1200目砂纸打磨5min;并在丙酮溶液中超声清洗6min;随后用纯水超声清洗5min,然后吹干,得到打磨后基体层;采用氧化铝颗粒在打磨后髋臼杯基体层上进行喷砂处理,得到喷砂后的髋臼杯基体层;对喷砂后髋臼杯基体层进行酸蚀处理,氧化铝颗粒的平均粒径为400μm,喷砂处理的压强为1MPa,喷砂处理的时间为60s;采用V(H2O):V(硫酸):V(盐酸)=20:8:4的混合酸进行酸蚀处理,得到酸蚀层,硫酸中H2SO4的质量浓度为50%,盐酸中HCl的质量浓度为36%,酸蚀处理的时间为100s。Surface pretreatment of the outer surface of the acetabular cup: the outer surface of the acetabular cup was sanded with 200-grit and 800-grit sandpaper for 3 min, and then polished with 1200-grit sandpaper for 5 min; and ultrasonically cleaned in acetone solution for 6 min; Ultrasonic cleaning with water for 5 min, and then blowing dry to obtain the polished base layer; sandblasting the polished acetabular cup base layer with alumina particles to obtain the sandblasted acetabular cup base layer; The cup base layer is acid-etched, the average particle size of alumina particles is 400 μm, the pressure of sandblasting is 1MPa, and the time of sandblasting is 60s; V(H 2 O): V (sulfuric acid): V (hydrochloric acid) )=20:8:4 mixed acid for acid etching to obtain an acid etching layer, the mass concentration of H2SO4 in sulfuric acid is 50%, the mass concentration of HCl in hydrochloric acid is 36%, and the time for acid etching treatment is 100s .

对酸蚀处理后的髋臼杯进行钛粉热喷涂,得到过渡层,热喷涂选用的钛粉的平均粒径为80μm,热喷涂后过渡层的厚度为110μm。The acid-etched acetabular cup is thermally sprayed with titanium powder to obtain a transition layer. The average particle size of the titanium powder selected for thermal spraying is 80 μm, and the thickness of the transition layer after thermal spraying is 110 μm.

对钛粉热喷涂后的髋臼杯进行激光熔覆钽涂层:采用钽颗粒的球形度为0.8,球形钽颗粒的平均粒径为28μm(钽颗粒的D50为25μm)。激光熔覆的功率为5KW,光斑直径为22mm,激光熔覆的光束扫描速度为110mm/min,采用流量为9L/min的氮气对激光熔覆的过程进行保护,得到钽涂层厚度为40μm、孔径大小为16μm、孔隙率为60%的髋臼杯钽涂层,该髋臼杯钽涂层的钽涂层的扫描电镜照片如图1所示。Laser cladding tantalum coating on the acetabular cup after thermal spraying of titanium powder: the sphericity of tantalum particles is 0.8, and the average particle size of spherical tantalum particles is 28 μm (D50 of tantalum particles is 25 μm). The power of laser cladding is 5KW, the spot diameter is 22mm, the beam scanning speed of laser cladding is 110mm/min, and the process of laser cladding is protected by nitrogen gas with a flow rate of 9L/min, and the thickness of the tantalum coating is 40μm, An acetabular cup tantalum coating with a pore size of 16 μm and a porosity of 60%, the scanning electron microscope photograph of the tantalum coating of the acetabular cup is shown in FIG. 1 .

在80℃的温度条件下、将髋臼杯钽涂层浸没在0.2mol/L的磷酸二氢钙和5mol/L的氢氧化钠溶液中,持续24小时的水热反应,最后采用去离子水超声清洗,得到具有纳米丝状钽酸钙(该纳米丝状钽酸钙的直径为25nm,长度为450nm)的表面功能层的髋臼杯骨科植入物,该表面功能层的微纳结构如图2的扫描电镜照片所示,髋臼杯骨科植入物的剖视图如图3所示,由图3可知,该髋臼杯骨科植入物包括基体层1、酸蚀层2、过渡层3、钽涂层4,其中分布在钽涂层4的纳米丝状钽酸钙的结构为微纳结构,需在电镜下观察(如图2),图3的剖视图的A处的局部放大图如图4所示,从图4可以清晰的看出钽涂层为多孔结构。At a temperature of 80 °C, the acetabular cup tantalum coating was immersed in 0.2 mol/L calcium dihydrogen phosphate and 5 mol/L sodium hydroxide solution for 24 hours of hydrothermal reaction, and finally deionized water was used. Ultrasonic cleaning obtains the acetabular cup orthopaedic implant with the surface functional layer of nano-filament calcium tantalate (the diameter of this nano-filament calcium tantalate is 25 nm, and the length is 450 nm), and the micro-nano structure of this surface functional layer is such as: As shown in the scanning electron microscope photo of FIG. 2 , the sectional view of the acetabular cup orthopaedic implant is shown in FIG. 3 . It can be seen from FIG. 3 that the acetabular cup orthopaedic implant includes a base layer 1 , an acid etching layer 2 and a transition layer 3 , Tantalum coating 4, wherein the structure of the nano-filament calcium tantalate distributed in the tantalum coating 4 is a micro-nano structure, which needs to be observed under an electron microscope (as shown in Figure 2). As shown in FIG. 4 , it can be clearly seen from FIG. 4 that the tantalum coating has a porous structure.

实施例2Example 2

实施例2与实施例1的区别在于,The difference between Example 2 and Example 1 is that,

钽颗粒的球形度为0.6,最终得到髋臼杯骨科植入物。The sphericity of the tantalum particles was 0.6, and the final acetabular cup orthopedic implant was obtained.

实施例3Example 3

实施例3与实施例1的区别在于,The difference between Example 3 and Example 1 is that,

钽颗粒的球形度为1,最终得到髋臼杯骨科植入物。The tantalum particles have a sphericity of 1, and the final acetabular cup orthopaedic implant is obtained.

实施例4Example 4

实施例4与实施例1的区别在于,The difference between Example 4 and Example 1 is that,

钽颗粒的球形度为0.5,最终得到髋臼杯骨科植入物。The sphericity of the tantalum particles was 0.5, and the final acetabular cup orthopedic implant was obtained.

实施例5Example 5

实施例5与实施例1的区别在于,The difference between Example 5 and Example 1 is that,

钽颗粒的平均粒径为5μm,钽颗粒的D50为6μm,最终得到髋臼杯骨科植入物。The average particle size of the tantalum particles is 5 μm, and the D50 of the tantalum particles is 6 μm, and finally the acetabular cup orthopaedic implant is obtained.

实施例6Example 6

实施例6与实施例1的区别在于,The difference between Example 6 and Example 1 is that,

钽颗粒的平均粒径为40μm,钽颗粒的D50为35μm,最终得到髋臼杯骨科植入物。The average particle size of the tantalum particles is 40 μm, and the D50 of the tantalum particles is 35 μm, and finally the acetabular cup orthopaedic implant is obtained.

实施例7Example 7

实施例7与实施例1的区别在于,The difference between Example 7 and Example 1 is that,

钽颗粒的D50为20μm,钽颗粒的平均粒径为22μm,最终得到髋臼杯骨科植入物。The D50 of the tantalum particles is 20 μm, and the average particle size of the tantalum particles is 22 μm, and finally the acetabular cup orthopaedic implant is obtained.

实施例8Example 8

实施例8与实施例1的区别在于,The difference between Example 8 and Example 1 is that,

钽颗粒的D50为30μm,钽颗粒的平均粒径为35μm,最终得到髋臼杯骨科植入物。The D50 of the tantalum particles is 30 μm, and the average particle size of the tantalum particles is 35 μm, and finally the acetabular cup orthopaedic implant is obtained.

实施例9Example 9

实施例9与实施例1的区别在于,The difference between Example 9 and Example 1 is that,

钽颗粒的D50为15μm,钽颗粒的平均粒径为20μm,最终得到髋臼杯骨科植入物。The D50 of the tantalum particles is 15 μm, and the average particle size of the tantalum particles is 20 μm, and finally the acetabular cup orthopaedic implant is obtained.

实施例10Example 10

实施例10与实施例1的区别在于,The difference between Example 10 and Example 1 is that,

钽颗粒的D50为35μm,钽颗粒的平均粒径为40μm,最终得到髋臼杯骨科植入物。The D50 of the tantalum particles is 35 μm, and the average particle size of the tantalum particles is 40 μm, and finally the acetabular cup orthopaedic implant is obtained.

实施例11Example 11

实施例11与实施例1的区别在于,The difference between Example 11 and Example 1 is that,

激光熔覆的功率为4.0KW,激光熔覆的光斑直径为20mm,激光熔覆的光束扫描速度为100mm/min,采用流量为8L/min的惰性气体或氮气对激光熔覆的过程进行保护,氧化铝颗粒的平均粒径为350μm,喷砂处理的压强为0.8MPa,喷砂处理的时间为45s;最终得到髋臼杯骨科植入物。The power of laser cladding is 4.0KW, the spot diameter of laser cladding is 20mm, the beam scanning speed of laser cladding is 100mm/min, and the process of laser cladding is protected by inert gas or nitrogen with a flow rate of 8L/min. The average particle size of the alumina particles is 350 μm, the pressure of sand blasting is 0.8 MPa, and the time of sand blasting is 45 s; finally, an acetabular cup orthopaedic implant is obtained.

实施例12Example 12

实施例12与实施例1的区别在于,The difference between Example 12 and Example 1 is that,

激光熔覆的功率为8.0KW,激光熔覆的光斑直径为25mm,激光熔覆的光束扫描速度为180mm/min,采用流量为12L/min的惰性气体或氮气对激光熔覆的过程进行保护,氧化铝颗粒的平均粒径为500μm,喷砂处理的压强为1.2MPa,喷砂处理的时间为90s;最终得到髋臼杯骨科植入物。The power of laser cladding is 8.0KW, the spot diameter of laser cladding is 25mm, the beam scanning speed of laser cladding is 180mm/min, and the process of laser cladding is protected by inert gas or nitrogen with a flow rate of 12L/min. The average particle size of the alumina particles is 500 μm, the pressure of sand blasting is 1.2 MPa, and the time of sand blasting is 90 s; finally, an acetabular cup orthopaedic implant is obtained.

实施例13Example 13

实施例13与实施例1的区别在于,The difference between Example 13 and Example 1 is that,

热喷涂选用的钛粉的平均粒径为70μm,最终得到髋臼杯骨科植入物。The average particle size of the titanium powder selected for thermal spraying is 70 μm, and the acetabular cup orthopaedic implant is finally obtained.

实施例14Example 14

实施例14与实施例1的区别在于,The difference between Example 14 and Example 1 is that,

热喷涂选用的钛粉的平均粒径为100μm,最终得到髋臼杯骨科植入物。The average particle size of the titanium powder selected for thermal spraying is 100 μm, and the acetabular cup orthopaedic implant is finally obtained.

实施例15Example 15

实施例15与实施例1的区别在于,The difference between Example 15 and Example 1 is that,

热喷涂选用的钛粉的平均粒径为60μm,最终得到髋臼杯骨科植入物。The average particle size of the titanium powder selected for thermal spraying is 60 μm, and the acetabular cup orthopaedic implant is finally obtained.

实施例16Example 16

实施例16与实施例1的区别在于,The difference between Example 16 and Example 1 is that,

热喷涂选用的钛粉的平均粒径为110μm,最终得到髋臼杯骨科植入物。The average particle size of the titanium powder selected for thermal spraying is 110 μm, and the acetabular cup orthopaedic implant is finally obtained.

实施例17Example 17

实施例17与实施例1的区别在于,The difference between Example 17 and Example 1 is that,

基体层为Ti-5Zr-3Mo-15Nb,最终得到髋臼杯骨科植入物。The matrix layer is Ti-5Zr-3Mo-15Nb, and finally the acetabular cup orthopaedic implant is obtained.

实施例18Example 18

实施例18与实施例1的区别在于,选择的钛合金材质为Ti-5Zr-3Mo-15Nb,产品为股骨柄。The difference between Example 18 and Example 1 is that the selected titanium alloy material is Ti-5Zr-3Mo-15Nb, and the product is a femoral stem.

对Ti-5Zr-3Mo-15Nb的股骨柄进行钽涂层处理,股骨柄的柄体直径为

Figure BDA0003074411460000081
股骨柄的CT值为160mm。The Ti-5Zr-3Mo-15Nb femoral stem is treated with tantalum coating, and the stem diameter of the femoral stem is
Figure BDA0003074411460000081
The CT value of the femoral stem was 160 mm.

对股骨柄的外表面进行表面预处理:对股骨柄的外表面先后经过200目、800目砂纸打磨3min,随后用1200目砂纸打磨5min;并在丙酮溶液中超声清洗6min;随后用纯水超声清洗5min,然后吹干,得到打磨后基体层;采用氧化铝颗粒在打磨后的股骨柄基体层上进行喷砂处理,得到喷砂后的股骨柄基体层;对喷砂后股骨柄基体层进行酸蚀处理,氧化铝颗粒的平均粒径为400μm,喷砂处理的压强为1MPa,喷砂处理的时间为60s;采用V(H2O):V(硫酸):V(盐酸)=20:8:4的混合酸进行酸蚀处理,得到酸蚀层,硫酸中H2SO4的质量浓度为50%,盐酸中HCl的质量浓度为36%,酸蚀处理的时间为100s。Surface pretreatment on the outer surface of the femoral stem: the outer surface of the femoral stem was sanded with 200-mesh, 800-mesh sandpaper for 3 minutes, then 1200-grit sandpaper for 5 minutes; and ultrasonically cleaned in acetone solution for 6 minutes; then ultrasonicated with pure water Wash for 5 minutes, and then blow dry to obtain the ground base layer; use alumina particles to sandblast the ground femoral stem base layer to obtain the sandblasted femoral stem base layer; Acid etching treatment, the average particle size of alumina particles is 400μm, the pressure of sandblasting treatment is 1MPa, and the time of sandblasting treatment is 60s; V (H 2 O): V (sulfuric acid): V (hydrochloric acid) = 20: 8:4 mixed acid is subjected to acid etching treatment to obtain an acid etching layer, the mass concentration of H2SO4 in sulfuric acid is 50%, the mass concentration of HCl in hydrochloric acid is 36%, and the acid etching treatment time is 100s.

对酸蚀处理后的股骨柄进行钛粉热喷涂,得到过渡层,热喷涂选用的钛粉的平均粒径为80μm,热喷涂后过渡层的厚度为110μm。The titanium powder was thermally sprayed on the acid-etched femoral stem to obtain a transition layer. The average particle size of the titanium powder selected for thermal spraying was 80 μm, and the thickness of the transition layer after thermal spraying was 110 μm.

对钛粉热喷涂后的股骨柄进行激光熔覆钽涂层:采用钽颗粒的球形度为0.8,球形钽颗粒的平均粒径为28μm(钽颗粒的D50为25μm)。激光熔覆的功率为5KW,光斑直径为22mm,激光熔覆的光束扫描速度为110mm/min,采用流量为9L/min的氮气对激光熔覆的过程进行保护,得到钽涂层厚度为40μm、孔径大小为16μm、孔隙率为60%的股骨柄钽涂层。Laser cladding tantalum coating on the femoral stem after thermal spraying of titanium powder: the sphericity of tantalum particles is 0.8, and the average particle size of spherical tantalum particles is 28 μm (D50 of tantalum particles is 25 μm). The power of laser cladding is 5KW, the spot diameter is 22mm, the beam scanning speed of laser cladding is 110mm/min, and the process of laser cladding is protected by nitrogen gas with a flow rate of 9L/min, and the thickness of the tantalum coating is 40μm, Femoral stem tantalum coating with a pore size of 16 μm and a porosity of 60%.

在80℃的温度条件下、将股骨柄钽涂层浸没在0.2mol/L的磷酸二氢钙和5mol/L的氢氧化钠溶液中,持续进行24小时的水热反应,最后采用去离子水超声清洗,得到具有纳米丝状钽酸钙(该纳米丝状钽酸钙的直径为25nm,长度为450nm)的表面功能层的股骨柄骨科植入物。At a temperature of 80 °C, the tantalum coating of the femoral stem was immersed in 0.2 mol/L calcium dihydrogen phosphate and 5 mol/L sodium hydroxide solution for 24 hours of hydrothermal reaction, and finally deionized water was used. Ultrasonic cleaning was performed to obtain a femoral stem orthopaedic implant with a surface functional layer of nano-filament calcium tantalate (the nano-filament calcium tantalate has a diameter of 25 nm and a length of 450 nm).

对比例1Comparative Example 1

对比例1与实施例1的区别在于,The difference between Comparative Example 1 and Example 1 is that,

激光熔覆的功率是8.5KW,最终得到髋臼杯骨科植入物。The power of laser cladding is 8.5KW, and finally the acetabular cup orthopaedic implant is obtained.

根据YY/T 0988.14-2016分别测试上述实施例1至18、对比例1得到的骨科植入物的钽涂层的孔径大小,并通过扫描电镜分别对上述实施例1至18、对比例1得到的骨科植入物的钽涂层的涂层孔隙率、钽涂层的厚度以及过渡层的厚度,并将测试结果列于表1。According to YY/T 0988.14-2016, the pore sizes of the tantalum coatings of the orthopaedic implants obtained in the above-mentioned Examples 1 to 18 and Comparative Example 1 were tested respectively, and the above-mentioned Examples 1 to 18 and Comparative Example 1 were obtained by scanning electron microscopy. The coating porosity, the thickness of the tantalum coating and the thickness of the transition layer of the tantalum coating of the orthopedic implants, and the test results are listed in Table 1.

表1Table 1

Figure BDA0003074411460000091
Figure BDA0003074411460000091

Figure BDA0003074411460000101
Figure BDA0003074411460000101

从上述表1可以看出,与实施例相比,对比例1得到的髋臼杯骨科植入物容易从骨组织上脱落,从而缩短了髋臼杯骨科植入物的使用寿命。As can be seen from the above Table 1, compared with the examples, the acetabular cup orthopaedic implant obtained in Comparative Example 1 is easy to fall off from the bone tissue, thereby shortening the service life of the acetabular cup orthopaedic implant.

从以上的描述中,可以看出,本发明上述的实施例实现了如下技术效果:From the above description, it can be seen that the above-mentioned embodiments of the present invention achieve the following technical effects:

本申请的钽涂层骨科植入材料一方面通过在基体层与钽涂层之间形成一种过渡层,从而减少了钽涂层与基体层之间的热应力,提高了钽涂层与过渡层的结合力;另一方面由于钽涂层的多孔结构为骨组织的长入提供了空间,增强了骨长入,从而改善了钽涂层的生物相容性和骨传导性,产生有利于细胞生长的微环境,进而促进骨组织向多孔钽涂层内部生长以形成独特的骨-植入物界面,显著增强钽涂层骨科植入物在骨组织中的稳定性和功能、加速了骨-植入物界面的骨整合,此外,本申请的钽涂层仅通过钽涂层结构的改进就提高了其骨-植入物界面的骨整合性,与通过引入非钽物质对钽涂层进行预处理的方法相比,本申请的骨科植入物生产成本低、非钽物质的潜在危害性小,具有更好的应用前景。On the one hand, the tantalum-coated orthopaedic implant material of the present application forms a transition layer between the base layer and the tantalum coating, thereby reducing the thermal stress between the tantalum coating and the base layer, and improving the relationship between the tantalum coating and the transition layer. On the other hand, the porous structure of the tantalum coating provides space for the ingrowth of bone tissue, which enhances the ingrowth of the bone, thereby improving the biocompatibility and osteoconductivity of the tantalum coating. The microenvironment for cell growth, which in turn promotes the growth of bone tissue into the porous tantalum coating to form a unique bone-implant interface, which significantly enhances the stability and function of tantalum-coated orthopedic implants in bone tissue, and accelerates bone growth. - Osseointegration of the implant interface, in addition, the tantalum coating of the present application improves the osseointegration of its bone-implant interface only through the improvement of the tantalum coating structure, which is in contrast to the tantalum coating by introducing non-tantalum substances Compared with the method of pretreatment, the orthopaedic implant of the present application has low production cost, less potential harm of non-tantalum substances, and has better application prospects.

以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and changes. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.

Claims (20)

1.一种钽涂层骨科植入材料,包括依次叠置的基体层、过渡层、钽涂层以及钽表面功能层,其特征在于,所述钽涂层的形成过程包括采用激光熔覆的方法将钽颗粒喷涂在所述过渡层上,所述基体层为钛或钛合金,所述过渡层的熔点低于钽的熔点,所述钽涂层为多孔结构,所述钽涂层的孔径大小为10~30μm,所述钽涂层的涂层孔隙率为30~80%;所述过渡层的厚度为90~180μm,所述钽涂层中钽颗粒的球形度为0.6~1,所述钽颗粒的平均粒径为5~40μm,所述钽颗粒的D50为20~30μm。1. a tantalum coating orthopaedic implant material, comprising a matrix layer, a transition layer, a tantalum coating and a tantalum surface functional layer stacked successively, it is characterized in that, the formation process of the described tantalum coating comprises adopting laser cladding. The method sprays tantalum particles on the transition layer, the base layer is titanium or a titanium alloy, the melting point of the transition layer is lower than the melting point of tantalum, the tantalum coating has a porous structure, and the pore diameter of the tantalum coating is The size is 10-30 μm, the coating porosity of the tantalum coating is 30-80%; the thickness of the transition layer is 90-180 μm, and the sphericity of the tantalum particles in the tantalum coating is 0.6-1, so the thickness of the transition layer is 90-180 μm. The average particle size of the tantalum particles is 5-40 μm, and the D50 of the tantalum particles is 20-30 μm. 2.根据权利要求1所述的钽涂层骨科植入材料,其特征在于,所述钽涂层的厚度为30~60μm。2 . The tantalum-coated orthopaedic implant material according to claim 1 , wherein the thickness of the tantalum coating is 30-60 μm. 3 . 3.根据权利要求1或2所述的钽涂层骨科植入材料,其特征在于,所述钽表面功能层为纳米丝状钽酸钙。3. The tantalum-coated orthopaedic implant material according to claim 1 or 2, wherein the tantalum surface functional layer is nano-filament calcium tantalate. 4.根据权利要求3所述的钽涂层骨科植入材料,其特征在于,所述纳米丝状钽酸钙的直径为20~35nm。4 . The tantalum-coated orthopaedic implant material according to claim 3 , wherein the nano-filament calcium tantalate has a diameter of 20-35 nm. 5 . 5.根据权利要求4所述的钽涂层骨科植入材料,其特征在于,所述纳米丝状钽酸钙的长度≤500nm。5 . The tantalum-coated orthopaedic implant material according to claim 4 , wherein the length of the nano-filament calcium tantalate is less than or equal to 500 nm. 6 . 6.根据权利要求1所述的钽涂层骨科植入材料,其特征在于,所述钛合金选自Ti-6Al-4V、Ti-6Al-17Nb、Ti-13Nb-13Zr、Ti-5Zr-3Mo-15Nb中的任意一种。6. The tantalum-coated orthopaedic implant material according to claim 1, wherein the titanium alloy is selected from the group consisting of Ti-6Al-4V, Ti-6Al-17Nb, Ti-13Nb-13Zr, Ti-5Zr-3Mo Any of -15Nb. 7.根据权利要求1所述的钽涂层骨科植入材料,其特征在于,所述过渡层为纯钛或Ti-6Al-4V。7 . The tantalum-coated orthopaedic implant material according to claim 1 , wherein the transition layer is pure titanium or Ti-6Al-4V. 8 . 8.一种包括权利要求1至7中任一项所述钽涂层骨科植入材料的钽涂层骨科植入物,其特征在于,所述钽涂层骨科植入物为髋臼杯、髋臼补块、股骨柄中的任意一种。8. A tantalum-coated orthopaedic implant comprising the tantalum-coated orthopaedic implant material according to any one of claims 1 to 7, wherein the tantalum-coated orthopaedic implant is an acetabular cup, Either acetabular patch or femoral stem. 9.一种权利要求1至7中任一项所述钽涂层骨科植入材料的制备方法,所述制备方法包括依次在基体层上形成过渡层、钽涂层以及钽表面功能层,其特征在于,所述钽涂层的形成过程包括采用激光熔覆的方法将钽颗粒喷涂在所述过渡层上,形成钽涂层,其中,所述激光熔覆的功率小于或等于8.0KW,所述钽颗粒的球形度为0.6~1,所述钽颗粒的平均粒径为5~40μm,所述钽颗粒的D50为20~30μm。9. A preparation method of the tantalum-coated orthopaedic implant material according to any one of claims 1 to 7, the preparation method comprising sequentially forming a transition layer, a tantalum coating and a tantalum surface functional layer on the base layer, wherein It is characterized in that, the formation process of the tantalum coating includes using a laser cladding method to spray tantalum particles on the transition layer to form a tantalum coating, wherein the power of the laser cladding is less than or equal to 8.0KW, so The sphericity of the tantalum particles is 0.6-1, the average particle size of the tantalum particles is 5-40 μm, and the D50 of the tantalum particles is 20-30 μm. 10.根据权利要求9所述的制备方法,其特征在于,所述制备方法包括:10. preparation method according to claim 9, is characterized in that, described preparation method comprises: 步骤S1,在所述基体层上喷涂钛粉末或钛合金颗粒,形成所述过渡层;Step S1, spraying titanium powder or titanium alloy particles on the base layer to form the transition layer; 步骤S2,采用所述激光熔覆的方法将钽颗粒喷涂在所述过渡层上,形成所述钽涂层;Step S2, using the laser cladding method to spray tantalum particles on the transition layer to form the tantalum coating; 步骤S3,将所述钽涂层与钙盐和强碱溶液进行水热反应,得到所述钽涂层骨科植入材料。Step S3, hydrothermally react the tantalum coating with a calcium salt and a strong alkali solution to obtain the tantalum-coated orthopaedic implant material. 11.根据权利要求9或10所述的制备方法,其特征在于,所述激光熔覆的功率为4.0~8.0KW。11. The preparation method according to claim 9 or 10, wherein the power of the laser cladding is 4.0-8.0 KW. 12.根据权利要求11所述的制备方法,其特征在于,所述激光熔覆的光斑直径为20~25mm。12 . The preparation method according to claim 11 , wherein the diameter of the light spot of the laser cladding is 20-25 mm. 13 . 13.根据权利要求12所述的制备方法,其特征在于,所述激光熔覆的光束扫描速度为100~180mm/min。13 . The preparation method according to claim 12 , wherein the beam scanning speed of the laser cladding is 100-180 mm/min. 14 . 14.根据权利要求13所述的制备方法,其特征在于,采用流量为8~12L/min的惰性气体或氮气对所述激光熔覆的过程进行保护。14 . The preparation method according to claim 13 , wherein the laser cladding process is protected by using an inert gas or nitrogen with a flow rate of 8 to 12 L/min. 15 . 15.根据权利要求10所述的制备方法,其特征在于,在所述步骤S1中,所述钛粉末或所述钛合金颗粒的平均粒径各自独立地为70~100μm。15 . The preparation method according to claim 10 , wherein, in the step S1 , the average particle size of the titanium powder or the titanium alloy particles is independently 70 to 100 μm. 16 . 16.根据权利要求9或10所述的制备方法,其特征在于,所述制备方法还包括:16. preparation method according to claim 9 or 10, is characterized in that, described preparation method also comprises: 对所述基体层进行表面预处理。Surface pretreatment is performed on the base layer. 17.根据权利要求16所述的制备方法,其特征在于,所述表面预处理的过程包括:17. The preparation method according to claim 16, wherein the process of the surface pretreatment comprises: 对所述基体层依次进行打磨处理,得到打磨后基体层;Carrying out grinding treatment on the base layer in turn to obtain a ground base layer; 采用氧化铝颗粒在所述打磨后基体层上进行喷砂处理,得到喷砂后基体层;Sandblasting is performed on the ground base layer by using alumina particles to obtain a sandblasted base layer; 对所述喷砂后基体层进行酸蚀处理,所述氧化铝颗粒的平均粒径为350~500μm。Acid etching is performed on the sandblasted base layer, and the average particle size of the alumina particles is 350-500 μm. 18.根据权利要求17所述的制备方法,其特征在于,所述喷砂处理的压强为0.8~1.2MPa。18. The preparation method according to claim 17, wherein the pressure of the sandblasting treatment is 0.8-1.2 MPa. 19.根据权利要求18所述的制备方法,其特征在于,所述喷砂处理的时间为45~90s;采用体积比为H2O:硫酸:盐酸=20:8:4的混合酸进行所述酸蚀处理,所述硫酸中H2SO4的质量浓度为40~50%,所述盐酸中HCl的质量浓度为30~40%。19. preparation method according to claim 18, is characterized in that, the time of described sandblasting is 45~90s; Adopt the mixed acid that volume ratio is H 2 O:sulfuric acid:hydrochloric acid=20:8:4 to carry out the process. In the acid etching treatment, the mass concentration of H 2 SO 4 in the sulfuric acid is 40-50%, and the mass concentration of HCl in the hydrochloric acid is 30-40%. 20.根据权利要求19所述的制备方法,其特征在于,所述酸蚀处理的时间为90~120s。20 . The preparation method according to claim 19 , wherein the time of the acid etching treatment is 90 to 120 s. 21 .
CN202110548474.XA 2021-05-19 2021-05-19 Tantalum-coated orthopedic implant material, preparation method thereof and orthopedic implant Active CN113289057B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110548474.XA CN113289057B (en) 2021-05-19 2021-05-19 Tantalum-coated orthopedic implant material, preparation method thereof and orthopedic implant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110548474.XA CN113289057B (en) 2021-05-19 2021-05-19 Tantalum-coated orthopedic implant material, preparation method thereof and orthopedic implant

Publications (2)

Publication Number Publication Date
CN113289057A CN113289057A (en) 2021-08-24
CN113289057B true CN113289057B (en) 2022-10-14

Family

ID=77322823

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110548474.XA Active CN113289057B (en) 2021-05-19 2021-05-19 Tantalum-coated orthopedic implant material, preparation method thereof and orthopedic implant

Country Status (1)

Country Link
CN (1) CN113289057B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114099777A (en) * 2021-11-19 2022-03-01 湖南普林特医疗器械有限公司 Multi-layer active coating for orthopedic implant and preparation method thereof
CN114686871B (en) * 2022-03-30 2023-07-25 中国兵器科学研究院宁波分院 Preparation method of biological porous coating based on powder oxygenation design
CN116479420B (en) * 2023-04-18 2025-07-11 西安交通大学 Compact nanocrystalline tantalum coating with compressive stress prepared on surface of titanium alloy and method
CN116636915A (en) * 2023-06-15 2023-08-25 湖南华翔医疗科技有限公司 A kind of tantalum-modified bone implant, preparation method and application thereof
CN117018275A (en) * 2023-06-19 2023-11-10 中国兵器科学研究院宁波分院 Implant material and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191106A1 (en) * 2002-11-08 2004-09-30 Howmedica Osteonics Corp. Laser-produced porous surface
CN102409195A (en) * 2011-12-02 2012-04-11 苏州大学 Preparation method of porous tantalum and device applied to same
CN102644078A (en) * 2012-05-16 2012-08-22 西安交通大学 Preparation technology of porous calcium gluconate tantalite/nono-funicular hydroxylapatite bioactive coating
US20140086962A1 (en) * 2012-02-07 2014-03-27 The Regents Of The University Of California Products of manufacture having tantalum coated nanostructures, and methods of making and using them
CN106693069A (en) * 2017-02-22 2017-05-24 华中科技大学 Method for preparing medical porous titanium-tantalum artificial bone and artificial joint, and products thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191106A1 (en) * 2002-11-08 2004-09-30 Howmedica Osteonics Corp. Laser-produced porous surface
CN102409195A (en) * 2011-12-02 2012-04-11 苏州大学 Preparation method of porous tantalum and device applied to same
US20140086962A1 (en) * 2012-02-07 2014-03-27 The Regents Of The University Of California Products of manufacture having tantalum coated nanostructures, and methods of making and using them
CN102644078A (en) * 2012-05-16 2012-08-22 西安交通大学 Preparation technology of porous calcium gluconate tantalite/nono-funicular hydroxylapatite bioactive coating
CN106693069A (en) * 2017-02-22 2017-05-24 华中科技大学 Method for preparing medical porous titanium-tantalum artificial bone and artificial joint, and products thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
丁玎.骨植入体表面钽基涂层的制备和生物学性能研究.《中国优秀博硕士学位论文全文数据库(博士) 工程科技Ⅰ辑》.2019,(第01期), *
骨植入体表面钽基涂层的制备和生物学性能研究;丁玎;《中国优秀博硕士学位论文全文数据库(博士) 工程科技Ⅰ辑》;20190115(第01期);第B022-90页 *

Also Published As

Publication number Publication date
CN113289057A (en) 2021-08-24

Similar Documents

Publication Publication Date Title
CN113289057B (en) Tantalum-coated orthopedic implant material, preparation method thereof and orthopedic implant
Swain et al. Effect of surface roughness on titanium medical implants
Liu et al. Plasma-treated nanostructured TiO2 surface supporting biomimetic growth of apatite
JP2010069311A (en) Medical implant and manufacture for the same
JP2012130715A (en) Open-pore biocompatible surface layer for implant, method for manufacturing the same, and use
WO2009017945A2 (en) Hydroxyapatite coated nanostructured titanium surfaces
CN112999414B (en) 3D printing titanium alloy and preparation method thereof
CN106676605B (en) Preparation method and applications with the porous pure titanium of lattice structure or titanium alloy surface multiporous biological active ceramic film
CN102220551A (en) Method for plasma spraying of Ca-P bioactive coating on surface of magnesium alloy
CN111363995B (en) Preparation method of medical metal bone implant material
CN110468401A (en) A kind of method that cold spraying prepares porous tantalum bioactivity coatings
KR101137645B1 (en) Bio-implantable Devices and Surface Reforming Method thereof
CN103834894B (en) A kind of method preparing titanium-polyethylene porous titanium coating in titanium alloy-based surface
Bakitian A comprehensive review of the contemporary methods for enhancing osseointegration and the antimicrobial properties of titanium dental implants
US7767250B2 (en) Bioceramic coating of a metal-containing substrate
CN103409715A (en) A kind of preparation method of porous TiO2/SiO2 composite coating
CN103536966B (en) A kind of preparation method of the doping of the Graphene for hard tissue substituting material calcium silicates coating
EP3195825B1 (en) Dental implant
CN102302799A (en) Preparation method of calcium-magnesium-silicon multiphase ceramic coating for titanium-based artificial joint handle
Chandra et al. Implant surface modifications: A review
CN100368027C (en) A method for improving the bioactivity of nano-titanium oxide coating by hydrogen ion implantation
CN111467577B (en) A kind of medical metal bone implant material
KR100989451B1 (en) Bioactive coating layer with improved surface roughness and manufacturing method thereof
Hadipour et al. Preparation and characterization of plasma-sprayed nanostructured-merwinite coating on Ti-6Al-4V
KR101353338B1 (en) Method for manufacturing biocompatible implant

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant